GIST is a Marathon, Not a Sprint
Overall survival in GIST patients has improved dramatically over the years. In 2019, the median Overall Survival (OS) is over 12 years when all Life Raft Group registry patients are combined. About 80% of [...]
Potential Treatment for Imatinib-Resistant GIST Explored
Dr. Ron DeMatteo GIST specialist surgeon Dr. Ron DeMatteo, along with colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC), has published a new paper in the April issue of Cancer Research with potentially [...]
Life Fest 2014: What’s New in the Science of GIST?
In addition to spending time catching up with fellow patients and caregivers and attending the myriad of useful workshops featured at Life Fest 2014, participants were treated to an update of what is new in [...]
Virtual roundtable about GIST with Jerry Call
Jerry Call, Science Director On Wednesday, September 17, the Life Raft Group hosted “Virtual Roundtable with Jerry Call,” the second session in its Virtual Roundtable series. The live Q&A with the LRG [...]
GIST Q&A with LRG Science Director Jerry Call on April 28
Join The Life Raft Group for a GIST Q&A with LRG Science Director Jerry Call to be held on April 28. Jerry will answer all of your GIST questions live!
LRG closes out 2012 in the spotlight: advocacy, support & research highlighted
The Life Raft Group is dedicated to the welfare and survival of GIST patients worldwide and we carry out our mission through research, patient support & education and advocacy. The LRG was highlighted in all three areas at the end of 2012 and we wanted to share the important work we’re doing with all of you.
GIST Member Story – Jerry Call
You sit alone in a dreary doctor’s office; evidence of his medical expertise and importance adorn the walls. Maybe you sit there with a loved one, equally as scared and unprepared as you. The doctor hands you a verdict that says your time is up. Well now what do you do?